Open Access Research article

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

Marie Hudson*, Janet Pope, Michael Mahler, Solène Tatibouet, Russell Steele, Murray Baron, Canadian Scleroderma Research Group (CSRG) and Marvin J Fritzler

Arthritis Research & Therapy 2012, 14:R50 doi:10.1186/ar3763

No comments have yet been made on this article.

Post a comment